Life Science Daily News

We’re pleased to see our Director and General Counsel, Larry Cohen, published today in Life Science Daily News.

In this article, Larry explores a critical issue facing biotech companies as innovation accelerates: how to communicate emerging science responsibly without creating unintended regulatory or commercial risk. The piece examines the interplay between real-world evidence, intellectual property strategy and off-label use, and why disciplined communication has become a strategic capability rather than a compliance exercise.

At Celex Oncology Innovations Ltd Oncology, we believe that strong governance and responsible innovation go hand in hand. Clear thinking at the intersection of law, regulation and science is essential to translating promising biology into durable clinical and commercial outcomes.

Congratulations to Larry on a thoughtful contribution to an important industry conversation.